No shared counterparties.
| Stage | ECVT | % of rev | SIGA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $250M | 100.00% | $41M | 100.00% | ECVT ×6.10 |
| Gross profit | $50M | 19.94% | $23M | 57.17% | SIGA +37.2pp |
| Operating income | $19M | 7.75% | $14M | 33.91% | SIGA +26.2pp |
| Pre-tax income | $15M | 5.96% | $15M | 36.22% | SIGA +30.3pp |
| Net income | $8M | 3.15% | $12M | 30.40% | SIGA +27.3pp |
| Stage | ECVT | SIGA | Gap · A − B |
|---|---|---|---|
| Revenue | $250M100.00% | $41M100.00% | ECVT ×6.10 |
| Gross profit | 19.94%$50M | 57.17%$23M | SIGA +37.2pp |
| Operating income | 7.75%$19M | 33.91%$14M | SIGA +26.2pp |
| Pre-tax income | 5.96%$15M | 36.22%$15M | SIGA +30.3pp |
| Net income | 3.15%$8M | 30.40%$12M | SIGA +27.3pp |